Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Combining Aspirin and Clopidogrel After Stroke

Evidence Against Routine Combination Therapy

  • The American Heart Association/American Stroke Association guidelines state that the addition of aspirin to clopidogrel increases the risk of hemorrhage and is not routinely recommended for ischemic stroke or TIA patients (Class III, Level of Evidence A) 1
  • The Management of Atherothrombosis with Clopidogrel in High-Risk Patients with TIA or Stroke (MATCH) trial showed no significant benefit of combination therapy (clopidogrel plus aspirin) compared to clopidogrel alone in reducing ischemic events 2
  • The combination therapy significantly increased the risk of major hemorrhage with a 1.3% absolute increase in life-threatening bleeding compared to monotherapy 3

Appropriate Antiplatelet Options After Stroke

  • For patients with noncardioembolic ischemic stroke or TIA, antiplatelet agents rather than oral anticoagulation are recommended (Class I, Level of Evidence A) 4
  • Acceptable single-agent options include aspirin (50-325 mg/day) 4, clopidogrel (75 mg/day) 4, and combination of aspirin and extended-release dipyridamole 4

Special Circumstances Where Combination May Be Considered

  • Recent acute coronary syndromes or after vascular stenting may require combination therapy 5

Selecting the Appropriate Antiplatelet Therapy

  • For most stroke patients, monotherapy with either aspirin, clopidogrel, or aspirin plus extended-release dipyridamole is recommended 6
  • Clopidogrel is a reasonable alternative for patients allergic to aspirin (Class IIa, Level of Evidence B) 1
  • The selection should be individualized based on patient risk factor profile 6, medication tolerance 6, and cost considerations (aspirin is significantly less expensive) 5

REFERENCES